Pharmaceuticals Company Demonstrate Promising Oral Formulation For Alzheimer's Disease
InMed Pharmaceuticals' INM-901: A Promising Oral Formulation for Alzheimer's Disease.
In recent years, the race to find effective treatments for Alzheimer's disease has intensified, driven by the rising prevalence of the condition and the challenges it poses to patients, caregivers, and healthcare systems worldwide. In this context, InMed Pharmaceuticals Inc., a company known for its innovative approaches to drug development, has made considerable strides with its small molecule drug candidate, INM-901. $InMed Pharmaceuticals (INM.US)$
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment